Purpose of the Test
- Identify patients eligible for targeted TKI therapies.
- Predict patient response to crizotinib and similar drugs.
- Provide precision treatment options beyond standard chemotherapy.
ALK and ROS1 Testing Cost | Lahalak Medical Platform
Advanced molecular testing for lung cancer patients to detect specific gene rearrangements, enabling personalized targeted therapy selection for improved survival rates and more effective disease management strategies.
Scientific name: ALK and ROS1 Gene Rearrangement Testing (IHC/FISH)
A precise laboratory analysis of lung tissue samples to detect ALK and ROS1 rearrangements. This test identifies patients eligible for targeted therapies like crizotinib, ensuring a more effective treatment plan.
Service type
Oncology Genetic Test
Duration
5-7 working days
Fasting
Fasting is not required
Included Services
- IHC Protein Analysis
- FISH Genetic Analysis
- Detailed Consultant Report
Medical Service Information
Target Groups
- Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC).
- Non-smokers diagnosed with pulmonary adenocarcinoma.
- Cases requiring molecular profiling before starting targeted treatment.
Technologies Used
- IHC technology for rapid protein expression screening.
- FISH technology for highly accurate gene rearrangement confirmation.
- Advanced molecular analysis to ensure diagnostic reliability.
Conditions & Notices
- Provision of tissue sample (Paraffin block)
- Copy of the pathology report required
Medical services you might also like
